Occuity

Developing #optical #medtech screening & monitoring devices for some of humanity's greatest health challenges - #diabetes #myopia #glaucoma #alzheimers #pm1

[Occuity @occuity]

We’ve just published a short write-up about our experience at 100% Optical this weekend and it’s safe to say the momentum around AX1 is building...Read more: https://t.co/S7vvoHnN2r
Register your interest in AX1: https://t.co/U3Ck39cRMT

#MyopiaManagement #EyeCare #100Optical

[Occuity @occuity]

We’re proud to share that Occuity has been named Innovator of the Year at the Thames Valley Business & Community Awards.

#MedTech #Innovation #HealthcareInnovation #Ophthalmology #UKBusiness

[Occuity @occuity]

If you’re heading to 100% Optical this weekend, stop by Birmingham Optical Stand L30. Occuity are running the AX1 Speed Scan Challenge, giving you the chance to experience fast, non-contact axial length measurement & see just how intuitive the AX1 is in real clinical hands.

[Occuity @occuity]

🚀 We’re bringing the "AX1 Speed Scan Challenge" to @100Optical - Visit us on stand L30 Birmingham Optical to take part.

✔ Try the AX1
✔ 3 x £1,000 cashback Prizes to be won*
✔ Get priority access on release

#myopiamanagement #myopia #100Optical #optometry #optician

[Occuity @occuity]

Today is the final day of our Republic crowdfunding campaign, so we thought we'd highlight what we said at the beginning & give you five simple reasons why we believe you should invest in Occuity.

https://t.co/PsAEBZE7od

[Occuity @occuity]

We’re proud to share that Occuity has been featured in Ingenia magazine, the @RAEng_news, quarterly publication showcasing inspiring engineering stories from across the UK.

You can read the full article here: https://t.co/wktQMXiYH2

#IngeniaMag

[Occuity @occuity]

In this short video, Richard recorded a simple walkthrough of our offices while Dan talks through who we are, what we do, and how the team operates day to day. It was filmed in a single take to give an authentic, unfiltered view of Occuity as it really is.
https://t.co/xzc4tSI7PE

[Occuity @occuity]

We passed our £1.1 million target on Republic and welcomed our 300th investor into the Occuity community.

Five days to go. Don’t miss your chance to be part of what comes next.

https://t.co/h9Ifu9dmhO

[Occuity @occuity]

We've passed £1million in our current raise on Republic. and are getting closer to our £1.1million target. The campaign will be closing soon. If you're interested in our work, but haven't yet invested, now is the time to take a closer look.
https://t.co/aGnRIjMf5t
#innovation

[Occuity @occuity]

Last week, our team achieved a major milestone: a world-first in vivo retinal imaging result using brand-new, non-invasive optical methods developed in our Reading labs.

👉 Join us for tonights webinar, https://t.co/SgD1mLG8Xd

#MedTech #Oculomics #Innovation #RetinalImaging

[Occuity @occuity]

Have you heard about Occuity and want to understand more about what we do - and where we’re headed? Join us for a special live Q&A Webinar with the leadership team.

👉 Learn more and register: https://t.co/rHWpYFnReH

[Occuity @occuity]

Last week, our CEO Dan Daly and CCO Mark Jenkins joined Jonathan Roy on the UK Investor Magazine Podcast
🎧 Listen here:
👉 https://t.co/rNPLM7Y3SD

If you have any questions or want to know more about what we’re building, feel free to get in touch.

[Occuity @occuity]

Our Republic Europe crowdfunding round is now live. Secure your priority access, log in now and invest. 👉 Invest here: https://t.co/CIu9anEGNw

[Occuity @occuity]

⏳ Why Priority Access matters: It allows you to maintain your shareholding, increase your position, or join the round before allocations fill. Once public, allocation is not guaranteed. Pre-register now: https://t.co/nunfZnRK40

[Occuity @occuity]

🚀 Get Priority Access now: https://t.co/fIPcxRAJUG

Don't invest unless you're prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Learn more: https://t.co/2KfPHBIS5k

#RepublicEurope

[Occuity @occuity]

We’re proud to share that our CEO Dr Dan Daly, was invited to join UK Prime Minister Sir Keir Starmer as part of the official UK Gov Trade Delegation to India.

👉 Read: https://t.co/oE0mwHq47V

#Oculomics #MedTech #Innovation #Healthcare #UKIndia #TradeMission #Diabetes #Myopia

[Occuity @occuity]

Our Crowdcube campaign closes in 12 hours https://t.co/l5hbElU4Nz

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment & you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://t.co/y25OSvlnRV

[Occuity @occuity]

Our Crowdcube campaign closes tomorrow.👉https://t.co/el3EAq8ZQB)

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment &you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://t.co/y25OSvlnRV

[Occuity @occuity]

⏰Crowdcube round closes in just 2 days! https://t.co/l5hbElU4Nz Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more https://t.co/y25OSvlnRV

[Occuity @occuity]

Don't forget to join us for our Webinar! https://t.co/9PzwbmPaPe

Dont invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://t.co/y25OSvlnRV